欧洲粒子治疗网络(EPTN)关于成人脑与颅底肿瘤光子或质子放疗后随访的共识
欧洲粒子治疗网络(EPTN)通过德尔菲法在24名国际神经肿瘤放疗专家中达成共识,针对成人脑肿瘤放疗后的毒性评估与随访提出分级推荐框架。共识按推荐等级(I级为最低医疗标准,II、III级分别为高级临床或研究可选评估)列出各结局域的临床终点与评估方法,并在相关处定义推荐转诊至特定器官专科的风险器官阈值剂量。该共识旨在实现统一毒性数据收集并促进协作,同时提供了在线工具。
要点
- 共识采用德尔菲法在24名国际神经肿瘤放疗专家中达成,推荐分I、II、III级。
- I级推荐为最低医疗标准,II级和III级分别为高级临床或研究环境中的可选评估。
- 按结局域列出各等级的临床终点和评估方法,并在相关处定义转诊至器官专科的风险器官阈值剂量。
核心结论
- 这些基于共识的随访推荐将使接受放疗的脑肿瘤患者能够收集统一的毒性数据。
- 采用该标准将促进协作,并可进一步推动针对这些患者的放射性毒性研究领域。
- 提供了在线工具(www.cancerdata.org)以在临床实践中实施该指南。
研究设计与样本
- 欧洲粒子治疗网络(EPTN)合作项目,采用德尔菲法在24名国际神经肿瘤放疗专家中达成共识,针对毒性终点、评估方法和时间点制定推荐。
主要发现
- 提出了使用多级推荐进行一致毒性评分和随访的基本框架。
- I级包括所有被认为是最低医疗标准的推荐,II级和III级分别为高级临床或研究环境中的可选评估。
- 按每个结局域列出了各等级的临床终点和评估方法。
- 在相关处定义了推荐转诊至特定器官专科的风险器官阈值剂量。
关键数值与推荐
- 推荐分为I级(最低医疗标准)、II级(高级临床可选评估)和III级(研究可选评估)。
- 按结局域列出各等级的临床终点和评估方法。
- 在相关处定义推荐转诊至特定器官专科的风险器官阈值剂量。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Treatment-related toxicity after irradiation of brain tumours has been underreported in the literature. Furthermore, there is considerable heterogeneity on how and when toxicity is evaluated. The aim of this European Particle Network (EPTN) collaborative project is to develop recommendations for uniform follow-up and toxicity scoring of adult brain tumour patients treated with radiotherapy. METHODS: A Delphi method-based consensus was reached among 24 international radiation-oncology experts in the field of neuro-oncology concerning the toxicity endpoints, evaluation methods and time points. RESULTS: In this paper, we present a basic framework for consistent toxicity scoring and follow-up, using multiple levels of recommendation. Level I includes all recommendations that are considered minimum of care, whereas level II and III are optional evaluations in the advanced clinical or research setting, respectively. Per outcome domain, the clinical endpoints and evaluation methods per level are listed. Where relevant, the organ at risk threshold doses for recommended referral to specific organ specialists are defined. CONCLUSION: These consensus-based recommendations for follow-up will enable the collection of uniform toxicity data of brain tumour patients treated with radiotherapy. With adoptation of this standard, collaboration will be facilitated and we can further propel the research field of radiation-induced toxicities relevant for these patients. An online tool to implement this guideline in clinical practice is provided at www.cancerdata.org.
引用
- De Roeck L, van der Weide HL, Eekers DBP, et al. The European Particle Therapy Network (EPTN) consensus on the follow-up of adult patients with brain and skull base tumours treated with photon or proton irradiation. Radiother Oncol. 2022. PMID: 35093408. doi:10.1016/j.radonc.2022.01.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。